A single center,open-lable,self-controlled clinical study of MEBO in the treatment of recessive dystrophic epidermolysis bullosa

BEB6678
Ms. Yang Yu
Shantou MEBO Pharmaceutical Co., Ltd, China
View in full page Ask a Question Views:95


Currently, there is no question has been asked, you are welcome to ask a question.

Return